NCT01246791View on ClinicalTrials.gov

Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Healthy
Interventions
DRUG

NPC-01

NPC-01, contains 1mg norethisterone and 0.02mg ethinyl estradiol will be administered orally under the fasting condition

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT01246791 - Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers | Biotech Hunter | Biotech Hunter